BRUSSELS – 30 July 2014 – COCIR welcomes Esaote as its latest corporate member. Esaote is a leading manufacturer of medical diagnostic systems.
Founded as a start-up in 1982 and headquartered in Italy, Esaote provides medical imaging solutions in Ultrasound and Dedicated MRI, complemented by Healthcare IT, technical service and interventional ultrasound products throughout a broad clinical spectrum, from prevention to diagnosis and treatment.
Carlos Faustmann, Chief Global Marketing and Domestic Sales Officer at Esaote said: “COCIR’s global reach in opening markets for its members beyond Europe fits with Esaote’s ongoing solid international expansion. Through an international distribution network, our Group operates in over 60 countries worldwide.”
As one of the world’s leading producers of medical diagnostic systems and also our heavy investment in Healthcare Information Technology, we have also decided to join COCIR to benefit from being represented by the EU industry voice for both medical imaging and eHealth” said Carlos Faustmann.
Nicole Denjoy, COCIR Secretary General, said, “We are delighted to have Esaote on board. Esaote is a key player in the field of Ultrasound, Dedicated MRI , Interventional and Healthcare IT. These technologies fit very well with the portfolio of research and innovation which COCIR represents through its membership. It will be a great opportunity to also increase accuracy of our global market intelligence activities in the sectors covered by Esaote”.
For more information, contact:
Esaote Group is a leading player in the biomedical equipment sector, with a particular focus on ultrasound, dedicated magnetic resonance, and software for managing the diagnostic process. Esaote has over 1,335 employees, 19% of which are employed in R&D activities. Esaote has industrial and research units in Italy (Genoa, Florence, Naples), the Netherlands (Maastricht) and China (Shenzhen). Esaote is internationally recognised as one of the “Top Ten” diagnostic imaging companies in the world and enjoys the co-operation of worldwide scientific and clinical research centres and universities. Esaote has filed more than 120 international patents.